摘要 |
Novel antiviral compounds of Formula (I): wherein: A represents hydroxy; R<SUP>1 </SUP>represents aryl, heteroaryl bonded through a ring carbon atom, or heterocyclyl bonded through a ring carbon atom, C<SUB>1-6</SUB>alkyl or -C<SUB>5-9</SUB>cycloalkyl, each of which may be optionally substituted; R<SUP>2 </SUP>represents substituted phenyl, or -(CH<SUB>2</SUB>)<SUB>n</SUB>C<SUB>5-7</SUB>cycloalkyl optionally substituted on the cycloalkyl; R<SUP>3 </SUP>represents heterocyclyl or heteroaryl; optionally substituted phenyl or optionally substituted -C<SUB>1-6</SUB>alkyl; R<SUP>4 </SUP>represents hydrogen; and salts, solvates and esters thereof processes for their preparation, pharmaceutical compositions comprising them, and methods of using them in HCV treatment are provided.
|